Round Rock Advisors LLC Grows Holdings in Pediatrix Medical Group, Inc. $MD

Round Rock Advisors LLC raised its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 150.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,891 shares of the company’s stock after buying an additional 22,783 shares during the period. Round Rock Advisors LLC’s holdings in Pediatrix Medical Group were worth $810,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. purchased a new position in Pediatrix Medical Group in the fourth quarter valued at $37,000. KBC Group NV acquired a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at about $65,000. Canada Pension Plan Investment Board acquired a new stake in shares of Pediatrix Medical Group in the second quarter valued at about $83,000. Smartleaf Asset Management LLC grew its position in shares of Pediatrix Medical Group by 10.6% in the third quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company’s stock valued at $101,000 after purchasing an additional 601 shares during the period. Finally, Quantbot Technologies LP acquired a new stake in shares of Pediatrix Medical Group in the second quarter valued at about $99,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analysts Forecast Growth

MD has been the topic of several research analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Truist Financial lifted their target price on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research report on Monday, April 13th. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 target price on shares of Pediatrix Medical Group in a research report on Monday. UBS Group dropped their target price on shares of Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 24th. Finally, Zacks Research lowered shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 23rd. Two analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus price target of $21.33.

Pediatrix Medical Group Stock Performance

MD opened at $23.18 on Tuesday. The firm has a market capitalization of $1.93 billion, a PE ratio of 11.95 and a beta of 0.72. Pediatrix Medical Group, Inc. has a twelve month low of $11.84 and a twelve month high of $24.99. The firm’s 50-day moving average price is $20.70 and its 200 day moving average price is $20.87. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.66.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Thursday, February 19th. The company reported $0.50 earnings per share for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). The business had revenue of $493.77 million for the quarter, compared to analyst estimates of $486.23 million. Pediatrix Medical Group had a return on equity of 19.59% and a net margin of 8.64%.The business’s revenue was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.51 earnings per share. As a group, sell-side analysts expect that Pediatrix Medical Group, Inc. will post 2.05 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.